●
STSA
Satsuma Pharmaceuticals, Inc.
$40.14M
Cluster buy
Discretionary Insider Activity
Date:
06/06/2023
Insiders:
TAKANASHI KEN, director, and 1 others
Prior trend:
23 months of no clear discretionary insider activity

Summary

A $40.14M cluster buy for Satsuma Pharmaceuticals, Inc. (STSA) on 06/06/2023 after 23 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $20.07M 06/08/2023 TAKANASHI KEN Director, a 10%+ owner 0000899243-23-014896
● Buy $20.07M 06/08/2023 Shin Nippon Biomedical Laboratories, Ltd. A 10%+ owner 0000899243-23-014866

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $20.07M 06/06/2023 TAKANASHI KEN Common Stock, $0.0001 par value Discretionary Purchase
● Buy $20.07M 06/06/2023 Shin Nippon Biomedical Laboratories, Ltd. Common Stock Discretionary Purchase

Stats

Prior max multiple:
16.5
Prior median multiple:
18.2

Metadata

Signal ID:
kPDEOGxjz9jLLaND
Detected on:
06/05/2023